Anavex Life Sciences Corp (AVXL)

[ridinbulls]

JBem....it's still not 100% known. Here is the email I sent to IR along with the response regarding possible September/future data releases.

Email from IR....
I know we have discussed data release in regards to end of the year or September. I emailed IR and basically there has been no further date specified for data release besides the end of the year. However, that doesn't mean it will not be released. Bottom line let's not get hopes up on any near term data release but let's look toward end of the year. Hopefully we get a SURPRISE but at this point that is specualtion. See email below.


Dear Xxxxx,

Thank you for your email and interest in Anavex Life Sciences Corp. (OTCQX: AVXL).

Anavex released initial clinical data from its Phase 2a trial of ANAVEX 2-73 and ANAVEX PLUS on July 22, 2015. A copy of the press release and poster presentation is attached.

PART A of the Phase 2a trial is expected to be completed by the end of the year. Anavex is seeking to expand PART B, the extension period, from 26 to 52 weeks at the request of study participants. As of this time, the company has not specified a timeframe to report additional results of the Phase 2a trial.

Please do not hesitate to contact our office if we can be of further assistance.

On behalf of Anavex Life Sciences Corp.,

Christine Payne
Primoris Group Inc.
Toll Free (North America): 1 [phone] Outside North America: [phone]
Fax: [phone]
[e-mail]

The contents of this e-mail are confidential and may be legally privileged. It is intended solely for the addressee. Access to this e-mail by anyone other than the addressee is unauthorized. If you are not the intended recipient (or responsible for delivery of the message to the recipient), you should inform the sender at the e-mail address from which this message was transmitted or call [phone] and delete this message from your system and destroy any hard copies. Unauthorized use, disclosure, copying or distribution is prohibited and may be unlawful.


-----Original Message-----
From: Xxxxxx
Sent: Monday, August 03, 2015 5:29 PM
To: [e-mail]
Subject: PIIa Topline Data Release

I am fascinated and excited with the science here at Anavex. Recently I decided to become an investor and was very excited to see the preliminary results of the PIIa trial. Several investors and I have been trying to establish if Top Line data will be released publicly or will we have to wait until the end of the year to see the Final results. Any clarity you can provide would be appreciated.

I/we are very encouraged concerning this potential treatment option for those suffering from Alzheimer's.

Thanks in advance,

Xxxxx

Please excuse any misspellings as this message was generated from my iPhone.